Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Jacopo Oieni

Post Doctoral Scientist

Post Doctoral Scientist

I completed my Ph.D. in 2020 at Technion – Israel Institute of Technology, Israel in nanotechnology, on the delivery of antisense oligonucleotides with biomimetic nanovesicles for osteoarthritis treatment. 

As a Postdoctoral research assistant, I joined Professor Matthew Wood’s group to study the therapeutic potential of antisense oligonucleotides in neuromuscular diseases. In particular, in collaboration with Takeda Pharmaceutical, I am interested in developing new antisense oligonucleotides for Duchenne Muscular Dystrophy (DMD).